BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36678684)

  • 1. Consideration of Commercially Available Hepatocytes as Cell Sources for Liver-Microphysiological Systems by Comparing Liver Characteristics.
    Horiuchi S; Kuroda Y; Komizu Y; Ishida S
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
    Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes.
    Sjogren AK; Liljevald M; Glinghammar B; Sagemark J; Li XQ; Jonebring A; Cotgreave I; Brolén G; Andersson TB
    Arch Toxicol; 2014 Jul; 88(7):1427-37. PubMed ID: 24912781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human-Induced Pluripotent Stem Cell-Derived Hepatocytes and their Culturing Methods to Maintain Liver Functions for Pharmacokinetics and Safety Evaluation of Pharmaceuticals.
    Inoue T; Iwazaki N; Araki T; Hitotsumachi H
    Curr Pharm Biotechnol; 2020; 21(9):773-779. PubMed ID: 32003687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
    Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
    Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency.
    Laemmle A; Poms M; Hsu B; Borsuk M; Rüfenacht V; Robinson J; Sadowski MC; Nuoffer JM; Häberle J; Willenbring H
    Hepatology; 2022 Sep; 76(3):646-659. PubMed ID: 34786702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful energy shift from glycolysis to mitochondrial oxidative phosphorylation in freshly isolated hepatocytes from humanized mice liver.
    Ikeyama Y; Sato T; Takemura A; Sekine S; Ito K
    Toxicol In Vitro; 2020 Jun; 65():104785. PubMed ID: 31991145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2.
    Kang SJ; Lee HM; Park YI; Yi H; Lee H; So B; Song JY; Kang HG
    Cell Biol Toxicol; 2016 Oct; 32(5):403-17. PubMed ID: 27287938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation.
    Wesseler MF; Taebnia N; Harrison S; Youhanna S; Preiss LC; Kemas AM; Vegvari A; Mokry J; Sullivan GJ; Lauschke VM; Larsen NB
    Acta Biomater; 2023 Nov; 171():336-349. PubMed ID: 37734628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines.
    Gao X; Liu Y
    Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.
    Lee-Montiel FT; Laemmle A; Charwat V; Dumont L; Lee CS; Huebsch N; Okochi H; Hancock MJ; Siemons B; Boggess SC; Goswami I; Miller EW; Willenbring H; Healy KE
    Front Pharmacol; 2021; 12():667010. PubMed ID: 34025426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
    Ohshita H; Tateno C
    Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system.
    Shinohara M; Arakawa H; Oda Y; Shiraki N; Sugiura S; Nishiuchi T; Satoh T; Iino K; Leo S; Kato Y; Araya K; Kawanishi T; Nakatsuji T; Mitsuta M; Inamura K; Goto T; Shinha K; Nihei W; Komori K; Nishikawa M; Kume S; Kato Y; Kanamori T; Sakai Y; Kimura H
    Sci Rep; 2021 Mar; 11(1):5437. PubMed ID: 33686099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway.
    Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X
    Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut-liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism.
    Kurniawan DA; Leo S; Inamatsu M; Funaoka S; Aihara T; Aiko M; Rei I; Sakura T; Arakawa H; Kato Y; Matsugi T; Esashika K; Shiraki N; Kume S; Shinha K; Kimura H; Nishikawa M; Sakai Y
    PNAS Nexus; 2024 Feb; 3(2):pgae070. PubMed ID: 38384383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development.
    Raasch M; Fritsche E; Kurtz A; Bauer M; Mosig AS
    Adv Drug Deliv Rev; 2019 Feb; 140():51-67. PubMed ID: 29908880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent stem cell-derived hepatocyte-like cells.
    Schwartz RE; Fleming HE; Khetani SR; Bhatia SN
    Biotechnol Adv; 2014; 32(2):504-13. PubMed ID: 24440487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term culture system based on a collagen vitrigel membrane chamber that supports liver-specific functions of hepatocytes isolated from mice with humanized livers.
    Watari R; Kakiki M; Oshikata A; Takezawa T; Yamasaki C; Ishida Y; Tateno C; Kuroda Y; Ishida S; Kusano K
    J Toxicol Sci; 2018; 43(8):521-529. PubMed ID: 30078838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.